children MS
Showing 1 - 25 of >10,000
Opioid Use, Unspecified Trial in Zurich (Fentanyl)
Recruiting
- Opioid Use, Unspecified
-
Zurich, SwitzerlandUniversity's Children Hospital
Feb 13, 2023
Multiple Sclerosis, Obesity Trial in Kansas City (behavioral telehealth, Treatment as Usual)
Active, not recruiting
- Multiple Sclerosis
- Obesity
- behavioral telehealth
- Treatment as Usual
-
Kansas City, MissouriUniversity of Missouri-Kansas City
Nov 1, 2022
Iron Deficiency, Anaemia in Children Trial in Phattalung (Dietary Iron Program)
Completed
- Iron Deficiency, Anaemia in Children
- Dietary Iron Program
-
Phattalung, Phattalung Province, ThailandMs Witchada Simla
May 18, 2023
Afebrile Seizure (Finding) Trial in Toulouse (Collection of blood and urine samples, Clinical examination)
Completed
- Afebrile Seizure (Finding)
- Collection of blood and urine samples
- Clinical examination
-
Toulouse, Midi-Pyrénées, FranceHôpital des enfants
Oct 27, 2021
Propionic/Methylmalonic Acidemias, Maple Syrup Urine Disease, Citrullinemia Trial in Aktobe (Obtaining Dry Blood Spots From
Recruiting
- Propionic/Methylmalonic Acidemias
- +28 more
- Obtaining Dry Blood Spots From Healthy Newborns (Aged 1-7 Days)
- +5 more
-
Aktobe, Aktobe Region, KazakhstanRegional perinatal center of Aktobe region
Jun 8, 2023
Hypoxic-Ischemic Encephalopathy, Birth Asphyxia Trial in India (Umbilical cord milking)
Not yet recruiting
- Hypoxic-Ischemic Encephalopathy
- Birth Asphyxia
- Umbilical cord milking
-
Belgaum, Karnataka, India
- +7 more
Aug 4, 2022
Secondary Electrospray Ionization - Mass Spectrometry in
Recruiting
- Respiratory Diseases
- +2 more
- Real-time SESI-MS breath analysis
- +4 more
-
Basel, SwitzerlandUniversity Children's Hospital Basel (UKBB)
Dec 10, 2021
Relapsing-Remitting Multiple Sclerosis Trial in Worldwide (Ocrelizumab, Ocrelizumab Placebo, Fingolimod)
Recruiting
- Relapsing-Remitting Multiple Sclerosis
- Ocrelizumab
- +3 more
-
La Jolla, California
- +66 more
Jan 27, 2023
Dengue Fever, Dengue Hemorrhagic Fever, Dengue Trial in Worldwide (Live, attenuated, dengue serotype 1, 2, 3, 4 virus, Placebo:
Completed
- Dengue Fever
- +2 more
- Live, attenuated, dengue serotype 1, 2, 3, 4 virus
- Placebo: (NaCl) 0.9% solution
-
Fortaleza, CE, Brazil
- +21 more
Mar 10, 2022
Recent-Onset Type 1 Diabetes Extension Study Evaluating
Enrolling by invitation
- Type 1 Diabetes Mellitus
- Teplizumab
- Placebo
-
San Diego, California
- +41 more
Jan 31, 2023
Pediatric Migraine Trial in Worldwide (Rimegepant/BHV3000, Matching )
Recruiting
- Pediatric Migraine
- Rimegepant/BHV3000
- Matching placebo
-
Birmingham, Alabama
- +204 more
Feb 2, 2023
Childhood Obesity Trial in Madrid (ENTREN, ENTREN-F, Control group)
Active, not recruiting
- Childhood Obesity
- ENTREN
- +2 more
-
Madrid, SpainMs. Sepúlveda. Coordinator of ENTREN Program. ANOBAS Group Resea
Nov 3, 2020
Intestinal Flora and Metabonomics of Appendicitis
Recruiting
- Appendicitis
- +2 more
-
Jinan, Shandong, ChinaThe First Affiliated Hospital Of Shandong First Medcial Unversit
Sep 5, 2023
Obesity and Pediatric Multiple Sclerosis
Recruiting
- Multiple Sclerosis
-
Philadelphia, Pennsylvania
- +1 more
Oct 31, 2022
Cognitive Dysfunction in MS: Using Altered Brain Oscillation to
Completed
- Pediatric Multiple Sclerosis
-
Toronto, Ontario, CanadaHospital for Sick Children
Jan 6, 2020
Children With Multiple Sclerosis Trial (MRI without injection of contrast product)
Not yet recruiting
- Children With Multiple Sclerosis
- MRI without injection of contrast product
- (no location specified)
Feb 17, 2022
Offspring Neurocognitive Development and Behaviour
Recruiting
- Multiple Sclerosis
- Exposure to methylprednisolone during pregnancy
-
Bochum, Germany
- +1 more
Aug 8, 2022
Hemophilia A Trial in Worldwide (PEGylated Recombinant Factor VIII, ITI)
Recruiting
- Hemophilia A
- PEGylated Recombinant Factor VIII
- ITI
-
Phoenix, Arizona
- +91 more
Jul 30, 2021
Neuromyelitis Optica Spectrum Disorder Trial in Worldwide (satralizumab, azathioprine (AZA), mycophenolate mofetil (MMF))
Active, not recruiting
- Neuromyelitis Optica Spectrum Disorder
- satralizumab
- +3 more
-
Birmingham, Alabama
- +52 more
Mar 16, 2022
Multiple Sclerosis Trial (Diroximel Fumarate, Avonex, Tysabri)
Not yet recruiting
- Multiple Sclerosis
- Diroximel Fumarate
- +3 more
- (no location specified)
Dec 12, 2022
Autonomic Activity of Self-limiting Focal Epilepsy?
Active, not recruiting
- Epilepsy; Syndrome, Seizures of Localized Onset
- electroencephalogram
-
Merkez, Balikesi̇r, TurkeyBalıkesir University Medical Faculty
Nov 14, 2023